← Leaderboards
Sandra Paige Story
Nubad, Llc
$5,237,925
Attributed
$5,237,925
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.8M · FY2016–24$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$5,237,925 · 6
By mechanism
R44$2,989,181 · 1
R43$2,248,744 · 5
Top collaborators
No co-investigators on record.
Most similar at Nubad, Llc
Same institution · by research overlap
- Dev Priya Arya$12,646,040
- Meredith Newby Spano$252,413
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionInnovationLeadCombatLegal PatentSolidStructureChemistryInterestRna BindingScreeningLibrariesGrowthCostHealth Care CostsTuberculosisRapid ScreeningPathogenPharmaceutical PreparationsGenerationsCell WallAntibioticsBacteriaLigand Binding
Grant awards (12)
Ototoxicity of modified aminoglycosides$999,975
R44 · FY2024 · AI · contact PI
Ototoxicity of modified aminoglycosides$999,976
R44 · FY2023 · AI · contact PI
A biophysical assay targeting SARS CoV-2 RNA$298,689
R43 · FY2023 · AI · contact PI
A biophysical assay targeting Gyrase RNA$226,497
R43 · FY2023 · AI · contact PI
Ototoxicity of modified aminoglycosides$989,230
R44 · FY2022 · AI · contact PI
A biophysical assay targeting SARS CoV-2 RNA$299,900
R43 · FY2022 · AI · contact PI
A biophysical assay targeting Gyrase RNA$294,506
R43 · FY2022 · AI · contact PI
A biophysical assay targeting an essential bacterial gene$193,989
R43 · FY2022 · AI · contact PI
A biophysical assay targeting an essential bacterial gene$294,506
R43 · FY2021 · AI · contact PI
A biophysical assay for RNA based resistance$139,801
R43 · FY2021 · AI · contact PI
A biophysical assay for RNA based resistance$288,889
R43 · FY2020 · AI · contact PI
Development of Aminoglycoside-Nucleic Acid Conjugates for Inactivation of an Antibiotic Resistance-Conferring Aminoglycoside Sensing Riboswitch$211,967
R43 · FY2016 · AI · contact PI